Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | EHMT2 | Q96KQ7 | 7/20 | 0.44 |
| ▸ | EHMT1 | Q9H9B1 | 5/20 | 0.44 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.40 |
| ▸ | BCL6 | P41182 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | AGER | Q15109 | 1/20 | 0.38 |
| ▸ | AURKA | O14965 | 1/20 | 0.38 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.38 |
| ▸ | CCR4 | P51679 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6818739 | 0.96 | SMN1; SMN2 (0.46) | SMN1; SMN2EHMT2EHMT1HRH4BCL6 | |
| SCHEMBL6233712 | 0.88 | ALDH1A1 (0.39) | EHMT2EHMT1HRH4BCL6KDM4E | |
| SCHEMBL5438494 | 0.88 | SMN1; SMN2 (0.45) | SMN1; SMN2BCL6KDM4EALDH1A1LMNA | |
| SCHEMBL6237774 | 0.85 | EHMT2 (0.45) | EHMT2EHMT1HRH4KDM4EALDH1A1 | |
| SCHEMBL5457407 | 0.82 | EHMT2 (0.53) | SMN1; SMN2EHMT2EHMT1BCL6KDM4E | |
| SCHEMBL4837987 | 0.81 | EHMT2 (0.50) | SMN1; SMN2EHMT2EHMT1BCL6KDM4E | |
| SCHEMBL6856412 | 0.81 | SPIN1 (0.40) | SMN1; SMN2EHMT2KDM4EALDH1A1LMNA | |
| SCHEMBL5556209 | 0.81 | SMN1; SMN2 (0.52) | SMN1; SMN2EHMT2EHMT1BCL6KDM4E | |
| SCHEMBL5420949 | 0.80 | EHMT2 (0.36) | EHMT2EHMT1HRH4BCL6KDM4E | |
| SCHEMBL4841050 | 0.77 | SMN1; SMN2 (0.39) | SMN1; SMN2BCL6KDM4EALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7335656-B2 | Stent with a disposed traiazine compound such as 6-(3-Chloro-4-methoxy-phenoxy)-N-cycloheptyl-N'-methyl-N'-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4-diamine for inhibiting smooth muscle proliferation; restenosis and atherosclerosis | REDDY US THERAPEUTICS, INC. (US) | 2008-02-26 | — | — | US | claimed |
| US-20070122444-A1 | Medical devices employing triazine compounds and compositions thereof | DR. REDDY'S LABORATORIES LTD. (IN) | 2007-05-31 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070122444-A1 | Medical devices employing triazine compounds and compositions thereof | AREG, TGFB1, TGFB2 | SMN1; SMN2 3890/4885EHMT2 2566/4885EHMT1 2678/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.